Navigation Links
Champions Oncology Reports Full Year 2011 Financial Results
Date:7/15/2011

s of the original human tumor.  The Company uses this technology in conjunction with related services to offer solutions for two customer groups:  Personalized Oncology Services ("POS") in which physicians and patients looking for information to help guide the development of personalized treatment plans, and Translational Oncology Services ("TOS") in which pharmaceutical and biotech companies seeking personalized approaches to drug development can lower the cost and increase the speed of developing new drugs and increase the adoption of existing drugs. The Company's Tumorgraft Technology Platform consists of processes, physical tumors and information that we use to personalize the development and use of oncology drugs.  The Company is building its Tumorgraft Technology Platform through the procurement, development and characterization of numerous Tumorgrafts (within several cancer types).  Tumorgrafts are procured through agreements with a number of U.S. and foreign institutions as well as through the Company's  POS business.  The Tumorgrafts are developed and tested through agreement with a U.S. based pre-clinical facility.

The Company provides Personalized Oncology Solutions services to oncologists by establishing and administering expert tumor panels for their patients to analyze medical records and test results, to assist in understanding conventional and experimental options and to identify and arrange for testing, analysis and study of the patients' cancer tissues, as appropriate.  Additionally, the Company offers personalized Tumorgraft development, drug studies and genome sequencing as part of its POS whereby physicians can evaluate the effects of cancer drugs on their patients' Tumorgrafts and understand the genetic make-up of their patient's tumor enabling them to better select treatment regimens that may be efficacious to the patient.

This press release contains "forward-looking statements" (within the m
'/>"/>

SOURCE Champions Oncology, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Champions Oncology (formerly Champions Biotechnology) Completes $9.4 Million Financing
2. Champions Biotechnology Changes Name to Champions Oncology
3. Champions Announces Technology Collaboration Utilizing Champions Tumorgraft™ Technology Platform for Oncology Drug Development
4. Champions Biotechnology Reports Fiscal 2011 Third Quarter Financial Results
5. Champions Biotechnology Reports Additions to its Management Team
6. Champions Biotechnology Reports Fiscal 2011 First Quarter Financial Results
7. Champions Biotechnology Reports Fiscal 2010 Third Quarter Financial Results
8. Champions Biotechnology Enters into Licensing Agreement with Yale University and Southern Research Institute for the Repurposing of Bithionol for Oncology
9. Champions Biotechnology to Present Data at AACR-EORTC 2009 Regarding the Predictability of Biomerk Tumorgraft(TM) Platform to Guide Personalized Cancer Treatment and Accelerate Oncology Drug Development
10. Champions Biotechnology Expands Collaboration to Test Oncology Therapeutic in Biomerk Tumorgrafts(TM)
11. Champions Biotechnology Reports Fiscal 2010 First Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... January 15, 2014 This webinar ... on nonclinical and clinical safety assessment in biosimilars. ... guide a path for biosimilar drug development, however ... of biosimilarity with regards to quality, safety and ... of biosimilar drug development and registration, development strategies ...
(Date:1/15/2014)... NC (PRWEB) January 15, 2014 ... an enhancement to its Online Web Portal for Life ... now have the ability to specify the subject matter ... nearly 50 life science sub-domains. This will help reduce ... and scientific fields, and decrease the likelihood of error. ...
(Date:1/14/2014)... Doylestown, PA (PRWEB) January 14, 2014 ... – 11 p.m. , Location: Warrington Country Club, 1360 ... Hepatitis B Foundation, the only national nonprofit organization solely ... improving the quality of life for those affected worldwide, ... 11 at Warrington Country Club in Warrington, Pa. ...
(Date:1/14/2014)... York, NY (PRWEB) January 14, 2014 ... initiated coverage of Alliqua, Inc. (OTCQB: ALQA). Alliqua ... and marketing proprietary products to serve the wound ... , In late 2012, Alliqua was restructured ... launched the company’s new strategy to become a ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2DTS Improves Efficiency for Life Science Document Translations 2Hepatitis B Foundation to Host Annual Crystal Ball Gala 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3
... in Dane County saw its largest single-year job increase in ... to the 2007 Greater Madison Area Directory of High-Tech Companies ... , Purchase online The 21st annual ... in 12 industry clusters. They reported more than $5.5 billion ...
... you, it was in the middle of a week's trip to ... a new trade office in that country. The initial part of ... ancient capitol of Agra (home to the Taj Mahal among other ... part of the trip. I promised to share with you both ...
... knows the Bay Area and Silicon Valley very well, but ... proposition to building a thriving technology industry, and it starts ... and CEO of the Information Technology Association of Wisconsin ... has been serving in place of former chief executive Jim ...
Cached Biology Technology:Directory shows high-tech growth spurt in Dane Co. 2Directory shows high-tech growth spurt in Dane Co. 3Directory shows high-tech growth spurt in Dane Co. 4A Midwest passage to India, Part II 2A Midwest passage to India, Part II 3A Midwest passage to India, Part II 4A Midwest passage to India, Part II 5A Midwest passage to India, Part II 6A Midwest passage to India, Part II 7A Midwest passage to India, Part II 8Wisconsin IT association names Gee president, CEO 2
(Date:4/15/2014)... research into parasites of cuttlefish, squid and octopus ... cycles, and shown how they may help in ... Sarah Catalano has described 10 new parasite species− ... of cephalopods (cuttlefish, squid and octopus). They ... described from Australian waters. , "Although dicyemid ...
(Date:4/14/2014)... forest moths in Finnish Lapland suggests that scientists may ... and plants because much of the harm is hidden ... moth species and found that 90 percent of them ... from 1978 to 2009. During that time, average annual ... and winter precipitation increased as well. , "You see ...
(Date:4/14/2014)... the greenhouse gas methane were found above shale gas ... an important emissions source, according to a study jointly ... have implications for the evaluation of the environmental impacts ... one of only a few to use a so-called ... the air above wells, identified seven individual well pads ...
Breaking Biology News(10 mins):Bizarre parasite may provide cuttlefish clues 2Moth study suggests hidden climate change impacts 2Moth study suggests hidden climate change impacts 3'Problem wells' source of greenhouse gas at unexpected stage of natural gas production 2
... major component of green tea could prove the perfect ... to a bacterial infection. In a new laboratory study, ... Research, and his colleagues have been studying the therapeutic ... a fatal immune response that kills 225,000 Americans every ...
... innovative new rheumatoid arthritis drug Actemra (tocilizumab) has ... symptoms of rheumatoid arthritis (RA) in patients who ... disease modifying agents (DMARDs). Exciting new data from ... breaker, at the American College of Rheumatology (ACR) ...
... LOS ANGELES (November 7, 2007) FIJI Water, one ... in the world, announced a Sustainable Growth Initiative today ... 2008. To achieve this, FIJI Water will account ... its products and then, through a combination of meaningful ...
Cached Biology News:In the laboratory, green tea proves a powerful medicine against severe sepsis 2New Actemra data shows significant benefit for patients suffering from rheumatoid arthritis 2New Actemra data shows significant benefit for patients suffering from rheumatoid arthritis 3FIJI Water announces sustainable growth initiative with commitment to help mitigate climate change 2FIJI Water announces sustainable growth initiative with commitment to help mitigate climate change 3FIJI Water announces sustainable growth initiative with commitment to help mitigate climate change 4FIJI Water announces sustainable growth initiative with commitment to help mitigate climate change 5
Anti-ACTH Immunogen: Porcine ACTH conjugated to BSA. Available Date: 38566...
Goat polyclonal to BACE1 ( Abpromise for all tested applications). entrezGeneID: 23621 SwissProtID: P56817...
... Immunogen: Peptide ... encompassing the human, mouse, and ... Accession Number: NM_000314 ... Routinely evaluated by immunoblot. ...
Mouse monoclonal [MN-8C4] to zona radiata ( Abpromise for all tested applications). Antigen: Purified eggshell proteins (zona radiata proteins and small amounts of zona pellucida proteins) from ...
Biology Products: